Recombinant measles AIK-C strain expressing current wild-type hemagglutinin protein

Vaccine

Volumn 22, Issue 3-4, 2004, Pages 309-316

  Kumada, Atsushi ^a   Komase, Katsuhiro ^b   Nakayama, Tetsuo ^c  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b KITASATO INSTITUTE   (Japan)

^c KITASATO UNIVERSITY   (Japan)

Author keywords

Measles virus; Reverse genetics; Vaccine strain

Indexed keywords

COMPLEMENTARY DNA; HEMAGGLUTININ; HYPERIMMUNE GLOBULIN; VIRUS DNA;

ANIMAL CELL; ARTICLE; CERCOPITHECIDAE; CYTOPATHOGENIC EFFECT; FEASIBILITY STUDY; GENOTYPE; KIDNEY CELL; MEASLES VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VERO CELL; VIRUS RECOMBINANT; VIRUS STRAIN; WILD TYPE;

EID: 0344665682     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2003.08.015     Document Type: Article

References (40)

1. Redd SC, Markowitz LE, Katz SL. Measles vaccine. In: Plotkin SA, Orenstein WA, editors. Vaccines. 3rd ed. Philadelphia: Saunders; 1999. p. 222-66.
2. Griffin DE, Bellini WJ. Measles virus. In: Knipe DM, Howley PM, editors. Fields virology. 4th ed. Philadelphia: Lippincott, Williams & Wilkins; 2001. p. 1267-312.
3. Rota J.S., Heath J.L., Rota P.A.et al. Molecular epidemiology of measles virus: identification of pathways of transmission and implications for measles elimination. J. Infect. Dis. 173:1996;32-37.
4. WHO. Global measles mortality reduction and regional elimination, 2000-2001. Parts 1 and 2. Wkly Epidemiol Rec 2002;77:50-5, 58-61.
5. Hirayama M. Measles vaccines used in Japan. Rev. Infect. Dis. 5:1983;495-503.
6. Sasaki K. Studies on the modification of the live AIK measles vaccine. I. adaptation of the further attenuated AIK measles virus (the strain AIK-L33) to chick embryo cells. Kitasato Arch. Exp. Med. 47:1974;1-12.
7. Makino S. Development and characteristics of live AIK-C measles virus vaccine: a brief report. Rev. Infect. Dis. 5:1983;504-505.
8. Nakayama T., Komase K., Uzuka R., Hoshi A., Okafuji T. Leucine at position 278 of the AIK-C measles virus vaccine strain fusion protein is responsible for reduced syncytium formation. J. Gen. Virol. 82:2001;2143-2150.
9. Tidjani O., Grunitsky B., Guerin N.et al. Serological effects of Edmonston-Zagreb, Schwarz, and AIK-C measles vaccine strains given at ages 4-5 or 8-10 months. Lancet. II:1989;1357-1360.
10. Bolotovski V.M., Grabowsky M., Clements C.J.et al. Immunization of 6- and 9-month-old infants with AIK-C, Edmonston-Zagreb, Leningrad-16 and Schwarz strains of measles vaccine. Int. J. Epidemiol. 23:1994;1069-1077.
11. Nkrumah F.K., Osei-Kwasi M., Dunyo S.K., Koram K.A., Afari E.A. Comparison of AIK-C measles vaccine in infants at 6 months with Schwarz vaccine at 9 months: a randomized controlled trial in Ghana. WHO Bull. 76:1998;353-359.
12. WHO. Standardization of the nomenclature for describing the genetic characteristics of wild-type measles viruses. Wkly Epidemiol Rec 2001;76:241-8.
13. Nakayama T., Mori T., Yamaguchi S.et al. Detection of measles virus genome directly from clinical samples by reverse transcriptase-polymerase chain reaction and genetic variability. Virus Res. 35:1995;1-16.
14. Yamaguchi S. Identification of three lineages of wild measles virus by nucleotide sequence analysis of N, P, M, F, and L genes in Japan. J. Med. Virol. 52:1997;113-1120.
15. Takahashi M., Nakayama T., Kashiwagi Y.et al. Single genotype of measles virus is dominant whereas several genotypes of mumps virus are co-circulating. J. Med. Virol. 62:2000;278-285.
16. Zhou J., Fujino M., Inou Y.et al. H1 genotype of measles virus was detected in outbreaks in Japan after 2000. J. Med. Virol. 70:2003;642-648.
17. Radecke F., Spielhofer P., Schneider H.et al. Rescue of measles viruses from cloned DNA. EMBO J. 14:1995;5773-5784.
18. Schneider H., Spielhofer P., Kaelin K.et al. Rescue of measles virus using a replication-deficient vaccinia-T7 vector. J. Virol. Methods. 64:1997;57-64.
19. Kobune F., Sakata H., Sugiura A. Marmoset lymphoblastoid cells as a sensitive host for isolation of measles virus. J. Virol. 64:1990;700-705.
20. Sato T.A., Fukuda A., Sugiura A. Characterization of major structural proteins of measles virus with monoclonal antibodies. J. Gen. Virol. 66:1985;1397-1409.
21. Sakata H., Kobune F., Sato T.A., Tanabayashi K., Yamada A., Sugiura A. Variation in field isolates of measles virus during an 8-year period in Japan. Microbiol. Immunol. 37:1993;233-237.
22. Saito H., Sato H., Abe M.et al. Isolation and characterization of the measles virus strains with low hemagglutination activity. Intervirology. 33:1992;57-60.
23. Takeda M., Kato A., Kobune F.et al. Measles virus attenuation associated with transcriptional impediment and a few amino acid changes in the polymerase and accessory proteins. J. Virol. 72:1998;8690-8696.
24. Takeda M., Takeuchi K., Miyajima N.et al. Recovery of pathogenic measles virus from cloned cDNA. J. Virol. 74:2000;6643-6647.
25. Takeuchi K., Miyajima N., Kobune F., Tashiro M. Comparative nucleotide sequence analyses of the entire genomes of B95a cell-isolated and Vero cell-isolated measles viruses from the same patient. Virus Genes. 20:2000;253-257.
26. Tatsuo H., Ono N., Tanaka K., Yanagi Y. SLAM(CDw150) is a cellular receptor for measles virus. Nature. 406:2000;893-897.
27. Tatsuo H., Okuma K., Tanaka K.et al. Virus entry is a major determinant of cell tropism of Edmonston and wild-type strains of measles virus as revealed by vesicular stomatitis virus pseudotypes bearing their envelope proteins. J. Virol. 74:2000;4139-4145.
28. Nielsen L., Blixenkrone-Moller M., Thylstrup M., Hansen N.J., Bolt G. Adaptation of wild-type measles virus to CD46 receptor usage. Arch. Virol. 146:2001;197-208.
29. Patterson J.B., Scheiflinger F., Manchester M., Yilma T., Oldstone M.B. Structural and functional studies of the measles virus hemagglutinin: identification of a novel site required for CD46 interaction. Virology. 256:1999;142-151.
30. Manchester M., Eto D.S., Valsamakis A.et al. Clinical isolates of measles virus use CD46 as a cellular receptor. J. Virol. 74:2000;3967-3974.
31. Schneider U., Bullough F., Vongpunsawad S., Russell S.J., Cattaneo R. Recombinant measles viruses efficiently entering cells through targeted receptors. J. Virol. 74:2000;9928-9936.
32. Schneider U., von Messling V., Devaux P., Cattaneo R. Efficiency of measles virus entry and dissemination through different receptors. J. Virol. 76:2002;7460-7467.
33. Rota J.S., Hummel K.B., Rota P.A., Bellini W.J. Genetic variability of the glycoprotein genes of current wild-type measles isolates. Virology. 188:1992;135-142.
34. Rota J.S., Rota P.A., Redd S.B., Redd S.C., Pattamadilok S., Bellini W.J. Genetic analysis of measles viruses isolated in the United States, 1995-1996. J. Infect. Dis. 177:1998;204-208.
35. Katayama Y., Shibahara K., Kohama T., Homma M., Hotta H. Molecular epidemiology and changing distribution of genotypes of measles virus field strains in Japan. J. Clin. Microbiol. 35:1997;2651-2653.
36. Tamin A., Rota P.A., Wang Z., Heath J.L., Anderson L.J., Bellini W.J. Antigenic analysis of current wild type and vaccine strains of measles virus. J. Infect. Dis. 170:1994;795-801.
37. Fournier P., Brons N.H., Berbers G.A.et al. Antibodies to a new linear site at the topographical or functional interface between the haemagglutinin and fusion proteins protect against measles encephalitis. J. Gen. Virol. 78:1997;1295-1302.
38. Jin L., Sun Y.J., Ge L., Brown D.W. Characterization of a new genotype of measles virus detected in China and England. Epidemiol. Infect. 121:1998;691-697.
39. Xu W., Tamin A., Rota J.S., Zhang L., Bellini W.J., Rota P.A. New genetic group of measles virus isolated in the People's Republic of China. Virus Res. 54:1998;147-156.
40. Hashimoto K., Ono N., Tatsuo H.et al. SLAM(CD150)-independent measles virus entry as revealed by recombinant virus expressing green fluorescent protein. J. Virol. 76:2002;6743-6749.